0001104659-24-006988.txt : 20240126 0001104659-24-006988.hdr.sgml : 20240126 20240126073023 ACCESSION NUMBER: 0001104659-24-006988 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240125 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37392 FILM NUMBER: 24564193 BUSINESS ADDRESS: STREET 1: 1668 S. GARFIELD AVENUE STREET 2: 2ND FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 BUSINESS PHONE: (626) 282-0288 MAIL ADDRESS: STREET 1: 1668 S. GARFIELD AVENUE STREET 2: 2ND FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 8-K 1 tm244161d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 25, 2024

APOLLO MEDICAL HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware	001-37392	95-4472349
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801

(Address of Principal Executive Offices) (Zip Code)

(626) 282-0288

Registrant’s Telephone Number, Including Area Code

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	AMEH	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 24, 2024, Apollo Medical Holdings, Inc. (the “Company”) announced a proposed name change. On January 25, 2024, the Company filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to change its corporate name from “Apollo Medical Holdings, Inc.” to “Astrana Health, Inc.”, effective as of 12:01 a.m. Eastern Time on February 26, 2024 (the “Name Change”). Pursuant to Delaware law, a stockholder vote was not necessary to effectuate the Name Change, and the Name Change does not affect the rights of the Company’s stockholders. The foregoing summary of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 8.01

Other Events.

In connection with the Name Change, the Company expects that its common stock, which trades on The Nasdaq Stock Market LLC, will cease trading under the ticker symbol “AMEH” and will commence trading on February 26, 2024 under the new ticker symbol “ASTH.” There will be no change to the CUSIP number for the Company’s common stock. Outstanding stock certificates for shares of the Company’s common stock will not be affected by the Name Change and will continue to be valid and need not be exchanged.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
3.1		Certificate of Amendment of Restated Certificate of Incorporation of Apollo Medical Holdings, Inc. (effective February 26, 2024).
104		Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	APOLLO MEDICAL HOLDINGS, INC.

Date: January 26, 2024	By:	/s/ Brandon Sim
	Name: Title:	Brandon Sim Chief Executive Officer and President

EX-3.1 2 tm244161d1_ex3-1.htm EXHIBIT 3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT

OF

RESTATED CERTIFICATE OF INCORPORATION

OF

APOLLO MEDICAL HOLDINGS, INC.

Apollo Medical Holdings, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows:

FIRST: The Restated Certificate of Incorporation of the Corporation (the “Certificate”) is hereby amended solely to reflect a change in the name of the Corporation by deleting ARTICLE I in its entirety and inserting the following new Article I in lieu thereof:

ARTICLE I

NAME

The name of the corporation hereby created shall be Astrana Health, Inc.

SECOND: The foregoing amendment was duly adopted by the Board of Directors of the Corporation in accordance with the applicable provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware.

THIRD: Except as hereby amended, the Certificate shall remain unchanged.

FOURTH: This amendment shall be effective as of 12:01 a.m. Eastern Time on February 26, 2024.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment of Restated Certificate of Incorporation to be executed by its duly authorized officer this 25^th day of January, 2024.

	APOLLO MEDICAL HOLDINGS, INC.


	By:	/s/ Brandon Sim
	Name:	Brandon Sim
	Title:	Chief Executive Officer and President

EX-101.SCH 3 ameh-20240125.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ameh-20240125_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ameh-20240125_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Jan. 25, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jan. 25, 2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-37392
Entity Registrant Name	APOLLO MEDICAL HOLDINGS, INC.
Entity Central Index Key	0001083446
Entity Tax Identification Number	95-4472349
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1668 S. Garfield Avenue
Entity Address, Address Line Two	2nd Floor
Entity Address, City or Town	Alhambra
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91801
City Area Code	626
Local Phone Number	282-0288
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock
Trading Symbol	AMEH
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 7 tm244161d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001083446 2024-01-25 2024-01-25 iso4217:USD shares iso4217:USD shares false --12-31 0001083446 8-K 2024-01-25 APOLLO MEDICAL HOLDINGS, INC. DE 001-37392 95-4472349 1668 S. Garfield Avenue 2nd Floor Alhambra CA 91801 626 282-0288 false false false false Common Stock AMEH NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://apollomed.net/role/Cover Cover Cover 1 false false All Reports Book All Reports ameh-20240125.xsd ameh-20240125_lab.xml ameh-20240125_pre.xml tm244161d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm244161d1_8k.htm": { "nsprefix": "AMEH", "nsuri": "http://apollomed.net/20240125", "dts": { "schema": { "local": [ "ameh-20240125.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ameh-20240125_lab.xml" ] }, "presentationLink": { "local": [ "ameh-20240125_pre.xml" ] }, "inline": { "local": [ "tm244161d1_8k.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://apollomed.net/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-25", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm244161d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-25", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm244161d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://apollomed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001104659-24-006988-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-006988-xbrl.zip M4$L#!!0 ( ,H[.EBQ*'7_+0, .8+ 1 86UE:"TR,#(T,#$R-2YX M],_T'U:\8VAI(T!)))TZ:E)4D#S?6E(^P%U,B2*\D!^O65 M?.%F($!;GN3=<\[N>G=EZB>CD*)G$))PUK \IV0A8#X/".LWK)N.?=HY:S8M M='+\^A72O_H;VT;G!&A00Q^X;S=9CQ^A2QQ"#7T"!@(K+H[0+::QL?!S0D&@ M,QY&%!1H1QJIAJI.VGD0K?NUT2Y]Q>M3H*S4F!M1 E[6@;W#@\/W<2;0PO(45?07+KB&G<7 M2Y@H:R]9@R=,*LS\.7R@)H19<-5-G7-0LA2ZGT))#@U@ 2?!=_K\V=4.C2]7 MJ\QB;%%$],Q.#-ID>EP3G,)WG3PR![U3*V(8KWO&]<5@(1(TK/0X MHY;K!= CC"2QLR7RD&U6)C:%ZF/"K+N+X*)2+"&X8L?).1(@-3VIJ:4-&3^# MK.?ZF/HQW8DZS6\=,[/G;[+PBO-=:D,/)3M8,]/2L"0QMZ"5V08">@U+MWI@ MYPW]HN8B2%,GRM"_ MS81!)HZTD/L/*Z>XNVWEF@+T/Y;<,OK%6NON_&KIY\7UJ^MRN5"(%19YW46: M?@):W$^DUE#,DYWS;&.RO;)=\9R1#*:9;I/$] ULET3.VR&)%=?YLOAR%=P< MS A5-@VZXK.P-NA2C@M4R=RR8R;/<:0A\'C,EQML,PBPE?]BM&]//_V:-R/%I$\P_@EW#[C %Q>#+1J#N MIFKZ^ =02P,$% @ RCLZ6/T< OO]"@ @(8 !4 !A;65H+3(P,C0P M,3(U7VQA8BYX;6S-G5UOX[@5AN\+]#]PW9L6&,<3!RV0[&07&4^R,#:;9&// M;-M%L: EQA%"DP$E)_:_+RF)LD3Q2$J*DIR+&8_X'NJE^)BDOHX__;C;4/1" M1)IP=CXZ/OHX0H1%/$[8^GST=3&^6,SF\Q%*,\QB3#DCYR/&1S_^\.<_(?GG MTW?C,;I*"(W/T!<>C>?L@7^/;O"&G*&?"","9UQ\C[YANE5;^%5"B4 SOGFF M)".RH-CQ&?K[T?08H_%X0+W?"(NY^'H_K^I]S++G]&PR>7U]/6+\!;]R\90> M17PSK,)%AK-M6M7VQ_%.$?Z()>SI3?ZUP2I \7BP]VZ7)^4CMM]SMZ\D1 M%^O)]./'X\D_?[E>1(]D@\<)4\W>#0(7ZWUC+QFK3^'@Z/CD^VJ7Q2!_\ M_ @*3LD]>4!Y,\^R_;-$*4T4":-RVZ,@#W8S5(B)BI\PLL89B=6.3M6.CO^A M=O27=\0/<>Z/M!SGR?N.="WR_V([:UM^\^&U'U>J-E[+ M3PV+9)?)"8S$VJ2JHF,$SO>03PQEW57M/&K42]5HSD6[[6IFS.M,272TYB^3 MF"2R[NF)^C!6'_)FR__\,>-R)7"Q2C.!HTS7E#?C?&0IGYB6E/)":%]81#V- M*Q63B,NIZ3D;T^(P%N$/@F^LNRU;S2V%?]!5%5\<%KD+P&A#)DC*MR(B;^J5 MNEOH*)6.-E0JU)**L/'7Q>B'7(-^UZK_?)H<:G'0T7()M-T0EBUEC986-(M= M=;/-E.[E>ED0G6PQ9/:QEB"E<=S!%W+'L=KY%<5KBWVCW%476VWI/FX4!M') M-D=F+U<:I$2^NOD+22.1/*OE?%<[&C+GG6XQV>K[FB8L!-K&8!)J6D\#^SU9 M)VIJ41;4^2U1&SN&,4#O>NCOM&W.!59Q$- ,<0C.%O4@5$5YXNB"L2VF]^29 MBRY\FC+7U-A,FK#4-4$Q8C$&HE%H42'V1,2O6WG&3@3=]T+14KKF K!JHF'( M@J+#[@T$I)+[960I,$L3-8#U0M*6.C_= ,RV3CT,75"< .;@4Y)*[Y>4Q2.A M5-T/P*Q_0+&)7=,"&S9Y:2N#(@:T!S*31Z R)!QL+E_4ZEPNDP8VMJ;W"4_+ M=A<_E3A8A$R' RG*PY"*\T12[39$#T,MI6MZ *LF-X8L*&+LWD!6"CG*]?XA MN63Q($0JG1] #)MV/$I1@' TG?6A(=4^P;A*T@C3PLN5W)9V-,^B=0T(:->$ MI"4,"A3('0A+$:"9R4.\ O,O@L4P7&I*/["TK-I1J60!@F)ZZ\-$Z;U ,ML* MT7 -SSBPU-E-V1ZSU?U90!<$*#WF6G=M"WD#%$\ST"7+DFROGJ>[V6Y61%@: MUY:X8@,RIYDPRX-@ 3!E,E#(D-*A0NBEY_5= I:IAQC!YI@RMP38338I:&H" M(L%J#*#AH,V?*?5"Q$R.3 +3.8O)[F>R!]O5TKEE K#9A,(0!42%W1F 12E& MN1I)N1J:(M=(L&9+3)AJD*" [ &D!'J4:+^DN)Y\!Y*0+U;6'IL-YD!Q &AT^T0($@&H6:43Y#F+.+BF=<>=YCQK1P M]S,>PRN4GBBW4 UJ0A.MSI" !OB$\"L$?JA>"8%3UX!4C5X(>XBCN6! M2LM_KA-&CL'V6[5NZ>JPVV3*(@R()-@=P$^I_* _(!6#;EDHT$S?T-2I?VBF M0Z&9!@W-]#W0+%]Y(-""N6_-7V M<#:H](),VZH5F(,L/%Q:WOI@40%J/:-"?&*2+ZQNQ9W@+PF+X"4S)/<"#&#: M2HVA#0\=N\$^?JH%L8[S.M84B_+>+XF6^1EEFB;M0TRA"0^2IK'>P:50^T3B MCJ<9IO].GCM/Q.UB+WA8#5LA:2C#0\5FKP^8(@;)(!\GUB6NZH:&]54RH]S= M*\ 66X=7@&N%04!@<]1^!;BX>E*(7'>S8E00#(P(S6)GG6PQ5?5QK2R,+FX; M:O5P_KV6&A]?9)7=A=X]<@8_(-"6N.IIR)SN;;,\B!X'3)F]GLM0KO-T-5YE MF$CMPW>MS-G,;MJI)G)=$$3OFFY:T[0N=]R;OXDDDWN>\[G)DDE%K4%#O&8L%I$B59PM:_R)-/D6!;JVPB5T# !C4- M;440*("V3 X.0J25CB&X$T1!2&1'Y"\!JL1"XO;AP3K;=XE=0=%O6,,!*X. MI->>"8L,&$>U"%2$H#S&+S;S--T2\29X+"&>$ +- R"U]"'B!)GLA:H(],G6 M@D1;.3_NCZ>K99)1V\EE6^)L3@+,53.241X$&X IDX6\#/$'=#S]Z^IO2$O+W^AK3T/^Y2YZE*8(\$*"7>9ZZ+>9-(?_NB8( M!#J,M4Y*2BG26A\O)!RFK'7_(F#M;1&P[ED$K$-K=%BA Y M+MVN:++&0'+"3K5K*#HLFWQ8I$&A OL#QXPJ!!UB7&>TS%.D; MIUN689&_2RYL(Q.@P/9" M$96G+T-24H>R3H MLOP9NGHF^*(>7[\T$D7JA8AB5D MBD ZQ#$UMY)A43^/RTW,,[(!WW;H#W%%T%#SFJ,^?1 T#31I,I6'-4^N\T"D M(GUF,ZHGMX>7> V1XY6QQ:"Q,*XI@F $M 4MB^N_%> G=]YV19/HBG(,7V5I M:!QGS&O;,Y+E'00!$=!V!:7(RX4H5WKI_\^8/8GM&- XR9#1T1 Z VP"=UPR"-1'OH!%<&H%NWI_"P] M9 $D\>?]/7D@0KUWL"2[[+/%;W4*G>BFJ M5X!6ZAFQL@KTNZH$Y;78?K^\ONE:?I*;]2;YUPJG1&[Y+U!+ P04 " #* M.SI8 $4M\UD' #75P %0 &%M96@M,C R-# Q,C5?<')E+GAM;,V<77/B M-A2&[SO3_^#2:R! MVW8I#L)&W:8S6[2D-UM>[,C; &:R!(CR0'^?24;6#XL M^>3&)[E(B'GU\3['EGULR1?O5BF/GJG23(K+1J=UUHBHB&7"Q.RR\67%2T,N&D(UW?_W\4V1_+GYI-J,AHSSI1^]EW!R)J7P;?28I[41E\)S]P6.62A^N[U<+EM"/I.E5$^Z%_)D33 MR/(2NK_2[++AVMTTN^RUI)JUNV=GG?8_GV['\9RFI,F$XQ;3QK:4JZ6L7.?\ M_+R=?[N5GBA7$\6W;?3:V^[L:K;?LH!^KR>:]77>O5L9$Y.'O;*9R*MP_S6W MLJ;;U.QTF[U.:Z63QA9^3E!)3A_H-')_;?1VK9*%Y%RF-&D):MKNV_9 VCW2 M=C4O-U=T>MFPD9K;ZKN_G76Z;USEOQZ(S'IA]TS-W([5B-H'#2\4U528W.NM MW7!0A*Z,W9]HLJW(M0_NFF'&J3>[2R=JNGTK2VUC]F.AW/1DVQ46>+=GOO@0/1R"/:?[WE#5Q-M%(G-MB9.)I3G]7^W MFB-)NX9>;4D\VAK+.W6H..[3?M2N5!Q)E5!E66_K(BH^B-7IKKE1M!=$V8J: M\9SQ79BG2J8^.AL2TM/1?5"VB7IH7MGV$]>'(2>S7OL/- 9<_UU77$G7.HVAL<%3Q$@^![F2!%T MBQ2!*R$RPA_H0JH*\(=*(._?,'F7>4/"_'=&E*&*KR&D3\1 V&\P87L<(O%^ M5$1HYOA @)^J@<1_1[WP\'A$0CZ>4\Y=$D<$:"\OTP.Q_X&)W>_S%8"_>7;G M=WMJ@;/?*P+$_^=KP7_B%BD"]U0QF=A3N@*P/Q$#J9]C4O-&CH=VFP[A+Y%#D*#EGI4U4[/]2HL#0]\10Y"AI:(7% MFH$/,J4..A,<5?QJ*'*4!+3*9,W,;X1A9NWN^G_.TLF/&Z>'K$]54,8H2:?/ M% K;[9T&8=S#C!#?8R64,4JN&3*'PGE@_2C"1R*AJX]T'0)](H621LDQ@_90 M4-\KEA*U'K.X>M XU4)AHV2688,HM!_):I185VS*BL>!U="]1:#L4=)*D%V4 M$(Q$+-5"[MTN'LC,'H_K@4R"0WI%06@X4/+-%UA'"O/GE@G:"86B M5 Y^1H07@(#-5X*]^S+L73AVE#RTTN8KP=Y[&?8>'#M*+EII$Q/[P'Z\4X]R MZ7D"[15#D:/DHA46,8'G9YH[=:_D,RMF1551/RD!18^8HH;-HN[PQ4D>LK=O ME5#>B.EJN3E,SO=2&\+_8XNJ*\ER/90Y8N(:,EKW#<8B[NZFA6\JT9$$RAJ[H'7 MS236WD-_[VOP##:48?781LT8OREF; \&,DTSL;E'XWDJYI%"\:*D?T%[-:,> M2\YB9IB8?;)7B(H17LZY3 >%C)+L^8W53/A>41=I:B^[\WE<;JF!NIM.?2-O M2 \ECI+K51O%)3_2.J/JI?Q+2D&C@)+V04W7/<[0.+/#WKK3G3RZ%3.>4>9$ M!66-DO+Y3-7,]K-\5,2MUANOTXGD_N4AI4(H890$+V"M9L@'_2C'>R2!@D7) M[$KM((T)-ZMX3L2,^FU$R/I\I)+;%W'![ M1-U-.)L1_TJR8 'P.AM,X@&K=:_?RY?\N'7<*LW[,;0?RK%[I%#@.$LD0_;J M1ITES-"DZ-*0"2)BFU+MUK5YLO/J4M X*RA!)I&N;W_C7+^4*10YXK-#CSV(N*\$%#SB0\2P6:3Y:8:Z/K-G^IX8LNEAB+^O!)0_X@/%L%FT^?-J M8$\\,QE^9GXDA-)&G I;:@T%\C@EG%]GF@FJ@V/+D1 *&7'.:ZDU%,@W*54S M.ZA]4')IYINUG2'8G@)0Z(@S6X-6<>"O?JPC+]:_!5MHTD-U*6@44-)5 MJ&F<<^O>2O[@J?5 !^6-F)B6&<-9,Y5-.(N'7)+@=?F!#,H7,0LML86"]YJ( M)Y4M3+R^5S*FU#T^T;NC#9 0 2N A@0Q/WT1"IS;!3)-W6(B&3^-Y]:TOLM, M_OY2V[_@38-@.6AH,!=Q HPC707I'PN]:'*]?J!3JMPTA4>Z,M>VH:?P11&@ M.#0^J&\4 F,H"=-%^\37K=W@WE!;?.-^N;>PVBW_ U!+ P04 " #*.SI8 M2\M2+>D3 #2; $0 '1M,C0T,38Q9#%?.&LN:'1M[3UK4^)*T]^M\C_, MRZGSE%M'+@D7$96G$%!915!P+^>+-4D&B.:VF43A_/JW9R:!!(** KO[U#F7 M9F@9Z(2W7;.DE)F5P*$4NU-=T:GJ1\;Y NI_Y;W=TY M'GG0#_I:]"0U\CRGDLT^/S]GGO,9VQUFIIA2R73089N/2Z'SUJG7177T&-=V9,023Z[ !I:M=F :.=25C3& MNGJ)78NBJQ=VU:E=D*6#E^@0/:8#QLOZ2HQFF"'Y=GI[->ON)?>?=GY5($2)H2-08(OF>&]M.K<,KIO!3"61!.?*:L6<%TRG&- MS+$[Q D-,$+.AQU=,E@*MI2%UK"C3]-#C)UIYP&F"N\8-,2@PC/7-@A-[,U; M8MU5V[<\=Y),<= 8&T!=;Q$T/(QUJK6;%]->V+$-PS:)EK$([U;(27(QQ:V+ M8 T^$?OGV-,]@U2/L^(36DWB8<2 I,D/7W\Z2=5MRR.6E^Y/'&"W*KZ=I#PR M]K+""+-L7#8 >_Q_Z30ZTXFA55"/>$?H&IND@L;:^ BU&OPO]SFY?G_7^U-N MG-=J7?A@LT#I]%M'YQOW;*[WL3G>AW-< 5!!GHYZS_#BX3T!_8()P'\UDU@: M_.^=&7AX/\ &):N DB*@ZK[K,D Z5;'QG6"W:6D-[)%[T7S5RXW;>NZ?]LW) MR2HH\A$430L$/JD#%A<;+4LCXTLRN<^!Q\R5\X5":06XI5.09>->N@^\CT MCU:!(=_W1M@E]%Z^Y\Y6 *'\V2IP&HR6;@ KOT#24N"*K4T0]28&.4D-0,4K M2,HY'NKK)G2Y)L_HUC:QM2\>[ ,!KC[@QJ3I3^$X3:>.@2<59-D6X8WZN,*L M@KC,W/@W7=.(Q8V/?86.U[X)L%1A5V/OEKFG&NT,F#JF&*5'[4M69^B5BRL88R!"#NR9 LDJH MZ,%6A0KERSU0@/@:7AEQEP^X1^G0QC-CJJ6"9@_DWAU-H40TJQM81@1:I(P*&R9)RM&0/@P8&.< MM[ZE"\:"\2YPTR28^BZI!E9>@3XAL+ ICH)!6P)?N(RE* (F\$[OQC%S30MX MP(V &!=YR\9R(\">[4::5^?!/(U)4"-(&\2R3=UZ#>WK?)G'FP0X;(]Q88&A M@55&;%"XA-##'F=A/'RR?X^=T"N;V!WJ5@7E4M7__"&5ZM,NT,;+: MW/H&27?QD*_G48IZ;3#5OU6:S#$H][=1JHST+V?T9MJY13VIW/-0S@WA.)1'&DJN7TY7SD M,>7W-K0T9/LV<($]W#:O^^BVV>W<]K>#L^N[U,>6ASP;!JHL]1=3EO+(=I%4 MW-,^[>[8 ^2-R);\ E%]5_=T@-0V@N_0R)A '\]1)Z@9]!,M$^5@*HYZV_.67^7QXIA!ISH!HK$ M/73P%X<65G,#HOYTDM+'7D4#Z";T'6EX,@&2B97D)F+$I*J?L>5C=X+DXCYB M@);*@"M;MM[KWO7O>?Z>[3D*5 MJM:ZG:NK#FHW&ZUZ[0I==*X:K>OSWCYJ7=! ZB+2FW=UI;H>RYOW79J7YOM@OI>Q\2*Z2SY M]HCCVD_,$N*>Z0VT@6LF!GX&G[;4%H(/3UO.Z\)F>1UW)F>Z08!(A;C)C#T< M.\-S56K?]$H?\B0S/*RP(J7S!_E#^2-IA,5TH',AYEJ>\RD#XPWVG\;^)O>D!-G5C4GG-3T7S MZ!Q+I/>X];!HM -!J(L^0WA(-9W'JB]JP(;)JMNFJ5.V<8I^)AFMS&VFET%- MTS'L"7%_"Y'"VAOSCY]^(@.9PT'"8GXF&7$+1M=VYE.2*+,\.MA<]K.=,L.+ MJWI-TUQ":?!QI5M$2O:? [7]=ZOXP[LK:A_RGPD(4U6I5"HCL*MS[ Y8R0[5 M(%?REZW7^PLED_(K.V[>?K25R*3U\N3P]*,J-QW7,888.\@ICA$W%Q1^; %]0.FX7PC?=4I=$ MBJ6VW'>&1*GIJ\UBY4@QF:A4M0Y6 \ L?=EL%R9;3YILUP8*C+]U9WE0?#NZ M4?J=A]Y%]V = HMAA"A$*N<6-BJWDX?O!12Q9*_K EMU!QNH.2:J[^E/!'4& MX' )_83V@%K$R-URKK>A:<\K1BE0#&9*-9?@Y:K@%(<7=XW^;?E.>J3S@(,MR.B>7 MRS]'6S<,?E;M^,\?95DZ.**H3PSB, 8$ = ^"\L,GQ49=G>8$+E-;+36.FP8P]&U'=] T/6\3VJ3%!%*)@.ICPD<$ 6P&.BN!8;$<@=U:^\P&. MB[ U"=L&[!S:,QO'EEZ=96FTLCDV_LXUNUQ&+NK6!PLB22G05Y@WFSM=C/CE MP-5_=74/E("ETKX5Y#XTV=]__S9LG7[WQN/FZ-U;"HIM&P1;_)!6="5()$,( MN7ST6NWDC2GC@T\AOYN\F\\!C3#7*)'(B6S@L3,%J" 7 W-@=A#936.;:'O2 M :J?W2(YG\M QPVGF/^:R0?-)!>820]6)!6D: W;X%S!PQK)-G)WJ8QOKNM/ M!Y_7;B*+)/QB]C$C$)104+AH'%(!IR4Y8A^Q+>:I=11R&='S7P/YM0TDS'B[ M+F'.FYT-Y6='6%SA0G:W+'GPG>:C(7F:^O"P=DM93LLO9C% :%J-4/KJTB(5 MM+2\IWQZF_V(OO]:T*]M0;ED"VI1ZA/W53OZ02>G3J%P6/ZR6@GV'7:T0-%O M;TUYDB[LJ6^SIJ#OEJQI[4EB) P561MQ(>]S%@^?(8D[F""+ S9L,&G[.,#? MV^N\6/T(&@TR\!):@UF)L5+D4+5<3-QNGXT(ST_S,]+O-+4^>S-.'&131T@U M,*4OFOGO.U$7,UBH-S$5V]BC+V]0BIFL,HEB;@N3"$];<6&1T,.!J3^/='@R M\P=KVKI^B[27GN)?51LVS;QE^UF!0YU(LL*M84DUO]=H7FD=N7A*WEDCG\>3 MJK(U&837\VSU\3WG<;GY=K9XUDTT,2:K* M7L#]@$! MHIUK3#7\0U@6:F/WD7CHZJJ^PMFMS>15:P#6LC06"!.D3)#*-PR@PR.L (0? MZ9JKYNL4@0@ABF8PAFCHVL_>:'<' FJ'E?@Q11H9Z)8XJ2N*GKEB&#/.53S% M:P-YM,?F1IA"92'Z;& $ M;F9-FV=KW!W<1!R\D'E&CS8UXX)$@1Q#*H0:?V0709P^"-&<34UY4M:>MKY S%LSUM]5T*U!@MV&XMX'8TUT OK";MX(+)P8D!""A5LV M3P]]2G@OD$RP9\C>T]-YRBC>76;"X;B,"4/^K -JYBTLF!JTN.1)IS ._ :V M5%8H.=OZ8>HG8U+TJ)5\&5:LLC)BIF,_G1CX&<0ICM>PB%%=-Q'-7[W$FH3MLH:Z,(V^%+#SW1ET!ZL6;L[[.27G#NJAQ$8 M?)../L$Z:<%2J,*RA]D*Z-ALI60A#1)K7 9%,19#C&P9#$"Q4SI\>)W)>"#6 M>1#'5%!,3IR$"&Y^!NV6\!.RVOS(N" 9^2B@?@IS2C]?[(. W24>HQ(@!.^- M!*%\\&5W)WSUBE$4+.$ZZ%&(C8B)#US;G")\B;,!$0Q:V)V',1A=$&QXHUBO M_=T=,ABP<.*)L#R&Y1%R)25ZLF&FST ""[ LHA)*&288)@CT&2<\ MGI5.T0 02YM_B#2;""B8#Q3!'"LFT(#WBS*/$$(SJ,_/:T'\9_-8S#?-0(!\ M"V"J0%,\$)KQ]YF!5H6(D(\ L8PVR+RHKSQP,FQ.[N[.#Y\=I)Z]UXG8BQ:@ M)1.(0X4.#WS#X,O4 E( 0@<3HTH5P*&0-4I.L9(7&7DF7*A()4D3;HGXWQ: MRHP\$_*>\4A7=&]W)Y^1CK.X*DP 37.@6G^[BDP]-QP23TJ?(#)LB0"9 . M4?/T J3,-HZR_>X+1SG#SIW'%P[Q"EF3O?=.,QOU_6L/P5OL[)=E!;G(U.7% M[#/JDB)QZP7;S(O2-3*L%A&"#- 2RNY/HYF:@6?:6#+[7OYCZWCXS M$8$!/((U]>MBS4'UNUZKBRQ^Q)FGB1$VA3Z)EY=889MS!Q8\W^-9H4@/&3O4 MV?I$.93@NKK 9\S[N"@X01KS74"><)-@U\IDP9=RAQ5PBJ6F/@F\W!-HOL;Y M:)$@*U;(=#=%^]^=@IX'@F;OG,;NLTK:+$K8J9EMB M.%>2MEYB.J/ Q(8N9%0:TS#;K: _ZO5F_>PL06T22R8?Y 30_')DNC[F\- V MX 9>HC/+3.@E74D>LQ)GMLB%I4DOOV3F+?DM&_5R_C[+&Q?B);;+%)=!5"NW MIG-K8Z>4*R0ZH2UHS/I4P@:">+T7Y ?\P4)V#>QAQ*\,)V,YL)\Y5Q>:.5 M\96*ME'TL4JQPVG^K>O$\W>SKOTVO];Y=:U_=[OF6T4W%0?K%KN&@YW$Y@>Q MH]4TL4?YP]?=(!-8.".PNY-T8>%^TNZFYAL3I&*?U5EY22BXHD\D>Q2X" VV M*%]PC=G;%[\EH0@ M8Z[U)"6G7@MEUAIMOGAY'GHI -W2;.!'5"MO/GZZD(%NGMPHVP.BZR.=#!8N)7%YI:GK$LI_3.!_-,K+'Z$.3ZMI M!?$+#WZ9H&^#$=B4,5GV&R?\W";[U9[J&W]1I7QZST]!\3L-(K_$0CZ/S_H: MO1P^UFZR-U?9[]J#=7GZI5Q6SHV6VVH]DI$TF9A?M:9F>H?4.OR;7/<>;E3S MVB]>-K[<7DHN/AV9G?+!9:WN^7[[YGPTKM&)_]"^O"F5\YV[X5/YJW/XO=.M MTVZI:3[V&C8U3?G.\FO9ZU%7^U[\W#;:C^WOD^+9X_E?)?GR+[=L:@=-R3=/ MKVMEY0L]'_R0SUO/V=."=OG4UF__D@X RI#DO,[!I3+^JUNLG>NJ<] 9C2QZ MDV_DOHZ^]&_^OH09.-;3M_'A^- ^_?ZUH>!>\6[@7!PVO\D_1I_/:N$/[_P_ M4$L#!!0 ( ,H[.EA[S^4?V 0 *\6 4 =&TR-#0Q-C%D,5]E>#,M M,2YH=&WE6&V/XC80_H[$?YA2W:J58'FYW:L*6:1 PI&*)8AD>[J/)C'$;; Y MQRQ+?WW'#F_'(=UMR[ZTMQ*;Q!E[9IX9/S..U0]O!^UBP>J[MH-7T']6Z(4# MMVU5\RN^K6Y>6QW?^0A!^''@WI2F@JLFU&L+!2&;TPR&= 5C,2>\G ^4(:"2 M34LX$:>.'CNO!7,B9XPW08O66J#H@ZJ0E,UP2+)9HDIMJ]-V'Q(V80K>7M:M M:@>M'CV%OHAR1:51>,$GV:+U/+JZ[CCT>E[7#EWP>V#?ND,'?^'S:/=[SZ-G M[ 8A>NC D;O>L.N/1_[8#CU_"/\OG^V1/QCX<.LZZ.X ^O[ \8;O@[)V^O(9 M3-AF\9,H^6.9*39=;P89CZE>M'9YS7BI;2]$F@JXI3&+2 I]D<:,SW!=CT>7 MY6*!0"3D0DBBF. @Y(QP]A>-@? 8Z /#E?D,EKBF-$.3-=PSJ984Q!140N$] MY53BPMV#509DM7T=***,K$-3LB*2PD]Z^"*-/RU%R[IK'\RSJG?M"VE>_(R6 MQ0+Q2*BDJ#.B4KL()(.I]F>5-2]^_/5% 'VY4/:\<1 V(43\QC33P,;0-V@)W.*9L20B92F:U "))VF-%* J9,0 M/J/ N%'#4115%@O'.G&5F*;4I)*-G-,=N.#I64QE@!XR2=7:I!?CF38(Y?0: M>:CU$TCHL3"!&0W,!%*B?EF[$2(SI<(C]"] MI9,=B"^B_04=QXP=8EG6J7JV':@WE[FK,_[:V#O<;RNS(PXW]Y8:)35,D"4D M36%"PE,:)XP9(4_52RLL%;$ M2V0L$HN%!@BQTA!V!)&QJ4A(.Y$2,CM%D^@DB1#MF/"(PHJIQ(B0Q2)%LIP@ M#2VDN&<9RIKY 2YE[NM7=<-DC:O&C@L?6R//%ZW_1%T+^]X8(^D^1!1GDN/* M4]X4E'VEVN2ZI'."<5KRO S%WQEL/?]N'/;U#L!BO4O\')MB 8F 3J7X)(,F8T;2P"SL4>Q<"?#C5H,$7_1DV4SI.#S1: M;AA*=T0Y:RU5(J1IQ<44YV/_;90VKJW@;M16B5755VR3R5HO_!OA.H"O)WJA MW<$.I>L.!L'([N)IZZ94*YGGD>TXV^='6[=BL4JT:.U-"R9(T%16(NP3R2*C M6+$W=R7S=<4*QUL%]SH,> #:>I)W&J7-1Q@K=';FA\Y^$+J^MGYX4VI\ZS$2 MI^._\:/U;P4W_EW7WI1.F_2YW-MO$[OZY7.Y?V3B245?'3RCJLZZ>=K+31YL MV\=.2J(_H8[)A(<6%I?:U:P*'6R*8MQS 9N?VZXALF_SV-:G4QJT>65,T>;9^!)L[.W:5]?_]#I0(]1M.X"2,R MHRV4_[2DV);ALBWP%Z;O:F)#E2FH5+:0.-[O6Q,.3QOUQHGCQCL]]K4'-D4$L! A0#% @ RCLZ6/T< OO]"@ @(8 !4 ( ! M7 , &%M96@M,C R-# Q,C5?;&%B+GAM;%!+ 0(4 Q0 ( ,H[.E@ 12WS M60< -=7 5 " 8P. !A;65H+3(P,C0P,3(U7W!R92YX M;6Q02P$"% ,4 " #*.SI82\M2+>D3 #2; $0 @ $8 M%@ =&TR-#0Q-C%D,5\X:RYH=&U02P$"% ,4 " #*.SI8>\_E']@$ "O M%@ % @ $P*@ =&TR-#0Q-C%D,5]E>#,M,2YH=&U02P4& 2 4 !0!& 0 .B\ end